John A Kollins is President and CEO of Satsuma Pharmaceuticals Inc.
Person profile
Roles
Satsuma Pharmaceuticals
President and CEO
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Jun 23 | STSA Satsuma Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.9 | 127,659 | 114.89 k | 0 |
8 Jun 23 | STSA Satsuma Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.9 | 127,659 | 114.89 k | 0 |
8 Jun 23 | STSA Satsuma Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.04 | 127,659 | 132.77 k | 0 |
8 Jun 23 | STSA Satsuma Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.56 | 276,595 | 1.26 mm | 0 |
8 Jun 23 | STSA Satsuma Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.46 | 505,000 | 1.75 mm | 0 |
8 Jun 23 | STSA Satsuma Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.6 | 240,000 | 1.10 mm | 0 |
8 Jun 23 | STSA Satsuma Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 29 | 175,000 | 5.08 mm | 0 |
6 Jun 23 | STSA Satsuma Pharmaceuticals | Common Stock, $0.0001 par value | Dispose U | No | No | 0.91 | 305,911 | 278.38 k | 0 |